Common multiple sclerosis treatment linked to bowel disease risk
People with multiple sclerosis (MS) who are treated with rituximab have an increased risk of developing inflammatory bowel disease, particularly Crohn's disease, although the absolute risk remains low. This is according to ...
50 minutes ago
0
0









